Summary of Significant Accounting Policies (Tables)
|
3 Months Ended |
Mar. 31, 2026 |
|---|
| Summary of Significant Accounting Policies [Abstract] |
|
| Schedule of Property and Equipment Estimated Useful Lives |
The Company depreciates its property and equipment
for financial reporting purposes using the straight-line method over the estimated useful lives of the assets. The estimated useful lives
are as follows:
| Building | | 40 years | | Building improvements | | 15 years | | Land improvements | | 15 years | | Machinery & equipment | | 5 years |
|
| Schedule of Property and Equipment |
Property and equipment consisted of the following
as of March 31, 2026 and December 31, 2025:
| | |
March 31,
2026 | | |
December 31,
2025 | |
| Land improvements | |
$ | 60,137 | | |
$ | 60,137 | |
| Buildings | |
| 1,302,401 | | |
| 1,302,401 | |
| Building improvements | |
| 2,275,583 | | |
| 2,275,583 | |
| Machinery and equipment | |
| 2,204,815 | | |
| 2,204,815 | |
| Total property and equipment | |
| 5,842,936 | | |
| 5,842,936 | |
| Less: accumulated depreciation | |
| (3,868,469 | ) | |
| (3,820,893 | ) |
| Property and equipment, net | |
$ | 1,974,467 | | |
$ | 2,022,043 | |
|
| Schedule of Intangible Assets |
Intangible assets consisted of the following as of March 31, 2026 and December 31, 2025:
| | |
March 31,
2026 | | |
December 31,
2025 | |
| Issued patents | |
| | |
| |
| Gross carrying amount | |
$ | 1,605,525 | | |
$ | 1,585,894 | |
| Less: accumulated amortization | |
| (769,291 | ) | |
| (749,467 | ) |
| Issued patents, net | |
| 836,234 | | |
| 836,427 | |
| Patents pending (not amortized) | |
| 1,159,540 | | |
| 1,155,196 | |
| Total intangible assets, net | |
$ | 1,995,774 | | |
$ | 1,991,623 | |
|
| Schedule of Potentially Dilutive Common Stock Equivalents |
The following table presents potentially dilutive
common stock equivalents that have been excluded from the calculation of dilutive loss per share as their inclusion would be anti-dilutive:
| | |
March 31,
2026 | |
| Holdback Shares | |
| 4,000 | |
| Warrants - Public | |
| 123,500 | |
| Warrants - Private | |
| 108,100 | |
| Warrants - Series A | |
| 508,857 | |
| Stock-based compensation - equity awards | |
| 6,000 | |
| Stock-based compensation - warrants | |
| 12,000 | |
| Total common stock equivalents excluded from dilutive loss per share | |
| 762,457 | |
The following table presents potentially dilutive
common stock equivalents that have been included in the calculation of dilutive income per share for the three months ended March 31,
2025, as their inclusion would be dilutive.
| | |
March 31,
2025 | |
| Stock-based compensation - equity awards | |
| 21,801 | |
| Total common stock equivalents included in dilutive income per share | |
| 21,801 | |
|
| Schedule of Composition of Other Current Assets |
The composition of other current assets was:
| | |
March 31,
2026 | | |
December 31,
2025 | |
| Directors & officers insurance | |
| 447,329 | | |
| 76,166 | |
| Total other assets | |
| 447,329 | | |
| 76,166 | |
|